Optomed Oyj Future Growth
Future criteria checks 5/6
Optomed Oyj is forecast to grow earnings and revenue by 60.8% and 29.8% per annum respectively. EPS is expected to grow by 68.6% per annum. Return on equity is forecast to be -7.2% in 3 years.
Key information
60.8%
Earnings growth rate
68.6%
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | 29.8% |
Future return on equity | -7.2% |
Analyst coverage | Low |
Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 30 | -1 | -3 | 3 | 2 |
12/31/2025 | 21 | -4 | -4 | 0 | 2 |
12/31/2024 | 15 | -5 | -1 | -3 | 3 |
9/30/2024 | 14 | -6 | -5 | -3 | N/A |
6/30/2024 | 15 | -5 | -3 | -1 | N/A |
3/31/2024 | 15 | -4 | -3 | -1 | N/A |
12/31/2023 | 15 | -4 | -3 | -1 | N/A |
9/30/2023 | 15 | -4 | -3 | 0 | N/A |
6/30/2023 | 15 | -5 | -4 | -2 | N/A |
3/31/2023 | 15 | -5 | -5 | -2 | N/A |
12/31/2022 | 15 | -5 | -5 | -2 | N/A |
9/30/2022 | 14 | -6 | -6 | -3 | N/A |
6/30/2022 | 14 | -5 | -6 | -3 | N/A |
3/31/2022 | 14 | -5 | -6 | -3 | N/A |
12/31/2021 | 15 | -4 | -6 | -3 | N/A |
9/30/2021 | 15 | -3 | -4 | -2 | N/A |
6/30/2021 | 15 | -2 | -4 | -2 | N/A |
3/31/2021 | 14 | -3 | -2 | 0 | N/A |
12/31/2020 | 13 | -3 | -5 | -3 | N/A |
9/30/2020 | 13 | -3 | -3 | -1 | N/A |
6/30/2020 | 13 | -4 | -3 | -1 | N/A |
3/31/2020 | 15 | -4 | -4 | -2 | N/A |
12/31/2019 | 15 | -3 | -1 | 0 | N/A |
9/30/2019 | 16 | -2 | -2 | 0 | N/A |
12/31/2018 | 14 | -1 | -2 | 0 | N/A |
12/31/2017 | 7 | -3 | N/A | -1 | N/A |
12/31/2016 | 7 | -3 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 36U0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 36U0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 36U0 is expected to become profitable in the next 3 years.
Revenue vs Market: 36U0's revenue (29.8% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 36U0's revenue (29.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 36U0 is forecast to be unprofitable in 3 years.